Dr JANNIER Sarah

Fiche personne

Coordonnées

Service de pédiatrie onco-hématologie
Hôpital de Hautepierre
Avenue Molière
67098 STRASBOURG Cedex

03 88 12 80 97

Territoire

Alsace

Statut

Hospitalier

Affiliation

Hôpitaux universitaires de Strasbourg (HUS)

Équipes/plateformes

Onco-hématologie pédiatrique

Recherche

Expertises :
- Clinique:Pédiatrie

Publications

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

Puzenat DT, Cheminant M, Dannaoui E, Sitterlé E, Alligon M, Gargala G, Molina T, Moshous D, Bustamante J, Picard C, Rosain J, Rouzaud C, Barlogis V, Stabler S, Malphettes M, Néel A, Jannier S, Parize P, Toubiana J, Reichert G, Suarez F, Neven B, Lanternier F, Lortholary O, Mahlaoui N, Melenotte C

J Infect Dis. 2026 06 30;:

Bilateral Wilms Tumor: Looking for the Best Surgical Strategy.

Martos Rodríguez M, Sudour-Bonnange H, Ducou Le Pointe H, Lemelle L, Bonneau-Lagacherie J, Pasqualini C, Boulanger C, Notz-Carrere A, Mansuy L, Pluchart C, Rod J, Jannier S, Sirvent N, Plantaz D, Klein S, Andry L, Verschuur A, Dumont B, Audry G, Irtan S

Ann Surg Oncol. 2026 06 4;:

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Gray JC, Weston R, Owens C, Canete A, Gambart M, De Wilde B, Nysom K, van Eijkelenburg N, Ladenstein R, Castellano A, Gerber NU, Marshall LV, Barone G, Rubio-San-Simon A, Ng A, Vaidya S, Gallego S, Makin G, Burke GAA, McCarthy A, Murphy D, Zwaan CM, López-Almaraz R, Jannier S, Thebaud E, Corradini N, Yeomanson D, Howell L, Tweddle DA, Elliott M, Hobin D, Valteau-Couanet D, Schleiermacher G, Chastagner P, Defachelles AS, Brichard B, George S, Chesler L, Laidler J, Firth C, Holt G, Moroz V, Pearson ADJ, Gates S, Wheatley K, Kearns P, Moreno L

J Clin Oncol. 2025 12 12;:JCO2501868

Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.

Pasqualini C, Proust S, Schleiermacher G, Gambart M, Jannier S, Petit A, Dupraz C, Thebaud E, Reguerre Y, Ndounga-Diakou LA, Laghouat S, Defachelles AS, Berlanga P

Pediatr Blood Cancer. 2025 10 3;:e32080

Desmoid-Type Fibromatosis Tumors in Children After First-Line Failure: Clinical Aspects and Approaches for Subsequent Therapeutic Lines.

Borovkov A, Orbach D, Bonneau-Lagacherie J, Carausu L, Guimard G, Haouy S, Jannier S, Pagnier A, Proust S, Verite C, Castex MP, Reguerre Y, Blouin P, Mansuy L, Métayer L, Corradini N, Defachelles AS, Boutroux H

Pediatr Blood Cancer. 2025 07 2;:e31866

Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee.

Sevrin F, Bogart E, Orbach D, Le Deley MC, Berlanga P, Bernier V, Corradini N, Fayard C, Guerin F, Jannier S, Karanian M, Proust S, Rome A, Verité C, Minard-Colin V, Defachelles AS

Cancer Med. 2024 12;13(23):e70420

Clinical impact of large genomic explorations at diagnosis in 198 pediatric solid tumors: a monocentric study aiming practical feasibility of precision oncology.

Simon J, Reita D, Guerin E, Lhermitte B, Weingertner N, Lefebvre F, Karanian M, Masliah-Planchon J, Lindner V, Onea A, Jannier S, Salmon A, Bergthold G, Vincent F, Deschuyter M, Barbaza MO, Entz-Werlé N

BMC Cancer. 2024 10 21;24(1):1296

Adolescent- and adult-onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020.

Magnier O, Schiff I, Cristante J, Chabre O, Veloso M, Bosson JL, Defachelles AS, Cordero C, Cao CD, Thebaud E, Drui D, Berlanga P, Dumont B, Chastagner P, Tandonnet J, Gambart M, Jannier S, Pluchart C, Andry L, Laithier V, Klein S, Carausu L, Akbaraly T, Probert J, Habert-Dantigny R, Plantaz D

Pediatr Blood Cancer. 2024 05 22;:e31074

Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis.

Lemelle L, Guillemot D, Hermann AL, Gauthier A, Carton M, Corradini N, Rome A, Berlanga P, Jourdain A, Marie Cardine A, Jannier S, Boutroux H, Defachelles AS, Aerts I, Geoerger B, Karanian M, Doz F, Brisse HJ, Schleiermacher G, Delattre O, Pierron G, Orbach D

Expert Rev Anticancer Ther. 2023 07 11;:

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.

Sabo AN, Jannier S, Becker G, Lessinger JM, Entz-Werlé N, Kemmel V

Pharmaceutics. 2021 Mar 30;13(4):

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers.

Jannier S, Kemmel V, Sebastia Sancho C, Chammas A, Sabo AN, Pencreach E, Farace F, Chenard MP, Lhermitte B, Geoerger B, Aerts I, Frappaz D, Leblond P, André N, Ducassou S, Corradini N, Bertozzi AI, Guérin E, Vincent F, Velten M, Entz-Werle N

Cancers (Basel). 2020 Oct 20;12(10):

The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.

Borocco C, Ballot-Schmit C, Ackermann O, Aladjidi N, Delaleu J, Giacobbi-Milet V, Jannier S, Jeziorski E, Maurier F, Perel Y, Piguet C, Oksenhendler E, Koné-Paut I, Galeotti C

Orphanet J Rare Dis. 2020 Apr 17;15(1):95

Rosacea and demodicidosis associated with gain-of-function mutation in STAT1.

Second J, Korganow AS, Jannier S, Puel A, Lipsker D

J Eur Acad Dermatol Venereol. 2017 Jun;:

Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1a axis inhibition.

Nguyen A, Moussallieh FM, Mackay A, Cicek AE, Coca A, Pierre Chenard M, Weingertner N, Lhermitte B, Letouzé E, Guérin E, Pencreach E, Jannier S, Guenot D, Jacques Namer I, Jones C, Entz-Werlé N

Oncotarget. 2017 Mar;:

Risk of cancer in children exposed to didanosine in utero.

Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S,

AIDS. 2016 05 15;30(8):1245-56